Protective Effect of Glucocorticoids against Symptomatic Disease in CSF1R Variant Carriers.

Jarosław DulskiMichael G HeckmanJulia M NowakZbigniew K Wszolek

Published in: Movement disorders : official journal of the Movement Disorder Society (2023)

We found a protective association of GCs in CSF1R variant carriers against developing CSF1R-related leukoencephalopathy. We call for further studies to validate our findings and investigate the potential application of GCs in CSF1R-related leukoencephalopathy. © 2023 International Parkinson and Movement Disorder Society.

Keyphrases

cerebrospinal fluid
drug induced
climate change
human health
case control